A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
Clinical trial NCT05827016 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05827016
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-22
- Primary completion
- 2029-03-15
- Enrollment
- 1230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.